Takahashi Eiichi, Fukuda Keiichi, Miyoshi Shunichiro, Murata Mitsushige, Kato Takahiro, Ita Makoto, Tanabe Tsutomu, Ogawa Satoshi
Institute for Advanced Cardiac Therapeutics, Shinanomachi Research Park, Keio University School of Medicine, Tokyo, Japan.
Circ Res. 2004 May 14;94(9):1242-8. doi: 10.1161/01.RES.0000126405.38858.BC. Epub 2004 Mar 25.
We have previously reported that leukemia inhibitory factor (LIF) gradually increased cardiac L-type Ca2+ channel current (I(CaL)), which peaked at 15 minutes in both adult and neonatal rat cardiomyocytes, and this increase was blocked by the mitogen-activated protein kinase kinase inhibitor PD98059. This study investigated the molecular basis of LIF-induced augmentation of I(CaL) in rodent cardiomyocytes. LIF induced phosphorylation of a serine residue in the alpha(1c) subunit (Ca(v)1.2) of L-type Ca2+ channels in cultured rat cardiomyocytes, and this phosphorylation was inhibited by PD98059. When constructs encoding either a wild-type or a carboxyl-terminal-truncated rabbit Ca(v)1.2 subunit were transfected into HEK293 cells, LIF induced phosphorylation of the resultant wild-type protein but not the mutant protein. Cotransfection of constitutively active mitogen-activated protein kinase kinase also resulted in phosphorylation of the Ca(v)1.2 subunit in the absence of LIF stimulation. In in-gel kinase assays, extracellular signal-regulated kinase phosphorylated a glutathione S-transferase fusion protein of the carboxyl-terminal region of Ca(v)1.2 (residues 1700 through 1923), which contains the consensus sequence Pro-Leu-Ser-Pro. A point mutation within this consensus sequence, which results in a substitution of alanine for serine at residue 1829 (S1829A), was sufficient to abolish the LIF-induced phosphorylation. LIF increased I(CaL) in HEK cells transfected with wild-type Ca(v)1.2 but not with the mutated version. These results provide direct evidence that LIF phosphorylates the serine residue at position 1829 of the Ca(v)1.2 subunit via the actions of extracellular signal-regulated kinase and that this phosphorylation increases I(CaL) in cardiomyocytes.
我们之前报道过,白血病抑制因子(LIF)可使心脏L型Ca2+通道电流(I(CaL))逐渐增加,在成年和新生大鼠心肌细胞中均于15分钟时达到峰值,且这种增加被丝裂原活化蛋白激酶激酶抑制剂PD98059阻断。本研究调查了LIF诱导啮齿类动物心肌细胞I(CaL)增强的分子基础。LIF可诱导培养的大鼠心肌细胞中L型Ca2+通道α(1c)亚基(Ca(v)1.2)的一个丝氨酸残基发生磷酸化,且这种磷酸化被PD98059抑制。当将编码野生型或羧基末端截短的兔Ca(v)1.2亚基的构建体转染至HEK293细胞时,LIF可诱导所得野生型蛋白发生磷酸化,但不能诱导突变蛋白发生磷酸化。共转染组成型活性丝裂原活化蛋白激酶激酶在无LIF刺激的情况下也可导致Ca(v)1.2亚基发生磷酸化。在凝胶内激酶分析中,细胞外信号调节激酶使Ca(v)1.2羧基末端区域(第1700至1923位氨基酸残基)的谷胱甘肽S-转移酶融合蛋白发生磷酸化,该区域包含共有序列Pro-Leu-Ser-Pro。此共有序列内的一个点突变导致第1829位氨基酸残基由丝氨酸替换为丙氨酸(S1829A),足以消除LIF诱导的磷酸化。LIF可使转染野生型Ca(v)1.2的HEK细胞中的I(CaL)增加,但不能使转染突变型Ca(v)1.2的HEK细胞中的I(CaL)增加。这些结果提供了直接证据,表明LIF通过细胞外信号调节激酶的作用使Ca(v)1.2亚基第1829位的丝氨酸残基发生磷酸化,且这种磷酸化可增加心肌细胞中的I(CaL)。